Cefuroxime Sodium Injection Market: Projected to Grow with Rising Demand for Injectable Antibiotics

Cefuroxime Sodium Injection Market

Cefuroxime sodium injection is used for various infections caused by sensitive bacteria, especially respiratory tract infections. COVID-19 has erupted in the world, and the demand for anti-infective drugs is rising, and these drugs are in short supply.

The global Cefuroxime Sodium Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Cefuroxime Sodium Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Cefuroxime Sodium Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-15M7880/Global_Cefuroxime_Sodium_Injection_Market_Insights_and_Forecast_to_2028

The major global manufacturers of Cefuroxime Sodium Injection include Hikma, Sagent, Pfizer, Teligent, SteriMax, Fresenius Kabi, Aglobal Care, Guangzhou Baiyunshan Tianxin Pharmaceutical and Sinopharm Weiqida Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cefuroxime Sodium Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cefuroxime Sodium Injection.

Report Scope

The Cefuroxime Sodium Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cefuroxime Sodium Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cefuroxime Sodium Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Type
• 0.25g/vial
• 0.5g/vial
• 0.75g/vial
• 1.5g/vial

By Application
• Hospital
• Clinic

Key Companies
Hikma, Sagent, Pfizer, Teligent, SteriMax, Fresenius Kabi, Aglobal Care, Guangzhou Baiyunshan Tianxin Pharmaceutical, Sinopharm Weiqida Pharmaceutical, Shanghai New Asia Pharmacetical, Harbin Pharmaceutical Group, Youcare Pharmaceutical Group, Weikang Pharmaceutical

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-15M7880/global-cefuroxime-sodium-injection

Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.